Wilcox Robert, Brænne Ingrid, Brüggemann Norbert, Winkler Susen, Wiegers Karin, Bertram Lars, Anderson Tim, Lohmann Katja
Department of Neurology, Flinders Medical Centre, Adelaide, Australia.
J Neurol. 2015 Jan;262(1):187-93. doi: 10.1007/s00415-014-7547-9. Epub 2014 Oct 31.
Dystonia is a movement disorder characterized by sustained or intermittent muscle contractions causing abnormal movements or postures. Several genetic causes of dystonia have been elucidated but genetic causes of dystonia specifically affecting females have not yet been described. In the present study, we investigated a large dystonia family from New Zealand in which only females were affected. They presented with a generalized form of the disorder including laryngeal, cervical, and arm dystonia. We found a novel, likely disease-causing, three base-pair deletion (c.443_445delGAG, p.Ser148del) in ATP1A3 in this family by combining genome and exome sequencing. Mutations in ATP1A3 have previously been linked to rapid-onset dystonia-parkinsonism (RDP), alternating hemiplegia of childhood (AHC), and CAPOS syndrome. Therefore, we re-examined our patients with a specific focus on typical symptoms of these conditions. It turned out that all patients reported a rapid onset of dystonic symptoms following a trigger suggesting a diagnosis of RDP. Notably, none of the patients showed clear symptoms of parkinsonism or symptoms specific for AHC or CAPOS. The ATP1A3 gene is located on chromosome 19q13.2, thus, providing no obvious explanation for the preponderance to affect females. Interestingly, we also identified one unaffected male offspring carrying the p.Ser148del mutation suggesting reduced penetrance of this mutation, a phenomenon that has also been observed for other RDP-causing mutations in ATP1A3. Although phenotypic information in this family was initially incomplete, the identification of the p.Ser148del ATP1A3 mutation elicited clinical re-examination of patients subsequently allowing establishing the correct diagnosis, a phenomenon known as "reverse phenotyping".
肌张力障碍是一种运动障碍,其特征为持续性或间歇性肌肉收缩,导致异常运动或姿势。肌张力障碍的几种遗传病因已得到阐明,但尚未描述专门影响女性的肌张力障碍的遗传病因。在本研究中,我们调查了一个来自新西兰的大型肌张力障碍家族,其中只有女性受影响。她们表现为该疾病的全身性形式,包括喉部、颈部和手臂肌张力障碍。通过结合基因组和外显子组测序,我们在这个家族的ATP1A3基因中发现了一个新的、可能致病的三碱基对缺失(c.443_445delGAG,p.Ser148del)。ATP1A3基因的突变先前已与快速发作的肌张力障碍-帕金森综合征(RDP)、儿童交替性偏瘫(AHC)和CAPOS综合征相关联。因此,我们重新检查了我们的患者,特别关注这些病症的典型症状。结果发现,所有患者在触发因素后均报告肌张力障碍症状迅速发作,提示RDP诊断。值得注意的是,没有患者表现出明显的帕金森综合征症状或AHC或CAPOS特有的症状。ATP1A3基因位于19号染色体q13.2上,因此,无法为女性易患倾向提供明显解释。有趣的是,我们还鉴定出一名携带p.Ser148del突变的未受影响的男性后代,提示该突变的外显率降低,这一现象在ATP1A3基因中其他导致RDP的突变中也有观察到。尽管这个家族的表型信息最初不完整,但p.Ser148del ATP1A3突变的鉴定引发了对患者的临床重新检查,随后得以确立正确诊断,这一现象被称为“反向表型分析”。